drugset
drugset / Trial / NCT00448071

Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients

NCT00448071 ↗

Phase 2 Unknown 12 enrolled Wolfson Medical Center Meditor Pharmaceuticals Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

MTR107 effect on blood pressure throught the dialysis procedure and its ability to prevent Intra dialytic Hypotension

Timeline

Start
2006-05
Primary completion
—
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject MTR107 Unknown — —

Indications

end stage renal failure hypotensive disorder